Escherichia coli strains that produce cytotoxins for HeLa or Vero cells are now recognized as important causes of diarrhea and hemorrhagic colitis (9, 32) . Enteral infections with cytotoxigenic E. coli have also been correlated with the onset of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura (4, 10, 20) . The cytotoxins are termed in reference to the Vero cell cytotoxin originally described by Konowalchuk et al. (21) as verotoxins or because of their biological similarity to Shiga toxin as Shiga-like toxins (SLTs) (33) . In E. coli isolates associated with human disease, two of these toxins have been purified (6, 17, 32, 34, 44) and their structural genes have been cloned and sequenced (3, 5, 12, 29, 30) . These studies revealed that one of the E. coli cytotoxins, called SLT-I, is almost identical at the DNA sequence level to the Shiga toxin from Shigella dysenteriae type 1 (3, 5, 39) , whereas a second toxin, termed SLT-II, is only 55% homologous with SLT-I (12) . There is evidence that variants of SLT-II exist in E. coli isolates of human (35; S. C. Head, M. A. Karmali (25a, 42) origin.
In intestinal and extraintestinal human diseases, in addition to E. coli serotype 0157:H7, E. coli isolates of numerous serogroups have been recognized as producers of SLTs (2, 9, 15, 19, 20, 25) . The identification of SLT producers that do not belong to serotype 0157:H7 is extremely difficult because there seem to be no differential biochemical or serological markers for this heterogeneous group of toxin producers. Therefore, identification must be based solely on tissue culture assays or on immunoassay. Enzyme-linked immunosorbent assay (ELISA) and colony blot ELISA with monoclonal antibody (MAb) against SLTs represent significant advances in the diagnosis of SLT-associated infections (6, 18, 35, 40) . Another line of research for identification of SLT-producing E. coli has recently been successfully directed toward the development of DNA probes. Levine et al. * Corresponding author. (23) have constructed a DNA probe from a 60-megadalton plasmid of E. coli serotype 0157:H7 which is also present in most toxigenic E. coli isolates of serotypes 026:H11, 0111: H8, and 0111:H-. Although this plasmid does not carry the structural genes for SLT production, DNA probes from the plasmid accurately identify enterohemorrhagic E. coli serotype 0157:H7 strains and about 70% of the SLT-producing E. coli strains that are non-0157 (23). Willshaw et al. (43) and Newland and Neill (28) constructed polynucleotide probes from the cloned SLT-I and SLT-II genes that were highly specific for the identification of SLT producers when compared with biological or serological assays.
In this study we constructed five synthetic oligonucleotides and tested them for the detection and characterization of SLT-I-and SLT-II-producing E. coli. We show that they specifically detect E. coli strains producing high levels of SLTs and examine the applicability of these probes for the colony hybridization technique.
(Part of this study appears in the thesis of T. Meyer.) MATERIALS AND METHODS Bacterial strains. The E. coli serotype 0157:H7 strains were obtained from the reference collections of the Centers for Disease Control, Atlanta, Ga.; from the Universitâts-krankenhaus Hamburg; and from M. A. Karmali, Toronto, Ontario, Canada. E. coli HB101(pJN26) and E. coli HB101(pJN28) have been described previously (29) and were kindly provided by J. Newland (Bethesda, Md.); E. coli C600 was obtained from A. Puhler (Bielefeld, Federal Republic of Germany). Some E. coli strains that were used have been recently characterized for SLT production by cytotoxicity tests (15) (16) (17) (18) sulfate at 30°C for 10 min and then once for 5 min at 50°C, air-dried, and autoradiographed at -80°C. Southern hybridization. Phage DNA, plasmid DNA, and chromosomal DNA were prepared as described by Maniatis et al. (24) . After treatment with restriction enzymes, the resulting fragments were separated by electrophoresis through 0.7% agarose gels and transferred to zetaprobe membranes by an alkaline Southern blotting procedure (37) . Prehybridization, hybridization, and washing of the membranes with covalently fixed DNA were carried out as described above for colony blots, except that 106 cpm of radiolabeled oligonucleotides per ml of hybridization solution was used.
RESULTS
Specificity of the oligonucleotide probes. The five oligonucleotides listed in Table 1 were tested for specificity by alkaline Southern hybridization. Representative results are shown for probes 772 ( Fig. 1) and 849 (Fig. 2) . Hybridization with probe 772, which was derived from the slt-IA gene, revealed the specific recognition of DNA from toxin-converting coliphage 933J (Fig. 1B, lane 1) and of SLT-I sequences present on pJN26 (29) , which is a recombinant pBR328 plasmid containing sequences homologous to this oligonucleotide probe. In Fig. 1B (lanes 6 and 7) , hybridization appeared with the excised SLT-I fragments of pJN26 but not with the vector pBR328. Furthermore, no hybridization signals occurred with pJN28 (29), a pBR328 derivative that lacks SLT sequences complementary to the probe used for hybridization (Fig. 1B, lane 5) . Similarly, no hybridization signals were detectable with pBR328 (Fig. 1B, lane 11) , plasmids of SLT-producing E. coli (Fig. 1B, lanes 2 and 3) , or A DNA (Fig. 1B, lane 4) . The same specificity was observed with the three other probes derived from the SLT-I genes (data not shown).
When we used the DNA samples shown in Fig. 1A , probe 849 complementary to sequences of the slt-IIA gene gave no hybridization signals (data not shown). To evaluate the capacity of this probe to detect SLT-II DNA sequences, we used genomic DNA from E. coli serotype 0157:H7 strain 933 that produces SLT-I and SLT-II (39) and genomic DNAs from E. coli C600 lysogenized either with the SLT-I-converting phage 933J or the SLT-II-converting phage 933W; E. coli C600 DNA was used as a control. The probe hybridized to single EcoRI fragments of about 5 kilobases from E. coli C600 lysogenized with phage 933W (Fig. 2B, lane 1 ) and E. coli serotype 0157:H7 strain 933 (Fig. 2, lane 2) but not to DNA from the SLT-I-producing strain or the nontoxigenic strain (Fig. 2B, lanes 3 and 4, respectively) . When this blot was reused for hybridization with the SLT-I-derived probe 772, a single EcoRI fragment of about 8.5 kilobases was only seen with E. coli 933 and E. coli C600 lysogenized with phage 933J (data not shown). The same specificities were obtained with the three other slt-I-derived probes. characterized for cytotoxicity in sonic lysates and culture filtrates by using both HeLa-S3 and Vero cells. For serological characterization, SLT-I producers were identified after growth on trimethoprim-sulfamethoxazole-containing agar plates by colony blot ELISA with MAb 13C4 (40) . For serological identification of SLT-II, filtrates of cultures grown overnight in Trypticase soy broth were examined by a dot blot ELISA with anti-SLT-II. In this assay cell-free cytotoxin that was present in culture supernatants was detected by anti-SLT-II, whereas the cytotoxic activity in culture supernatants from SLT-I producers was not reactive with anti-SLT-II.
Colony blot hybridization. Next, we used the synthetic oligonucleotides as hybridization probes in the DNA colony hybridization technique with strains classified as producers of SLT-I or SLT-II, producers of SLT-I and SLT-II, or producers of no toxin, as described above. Table 2 shows the ability of the five oligonucleotide probes to hybridize with some representative E. coli strains. Two E. coli serotype 0157:H7 isolates (strains 933 and HC3159; Table 2 ) expressed both SLT-I and SLT-II. They were reactive with all five oligonucleotides. Three strains serologically characterized as SLT-I producers hybridized with all four probes derived from the SLT-I genes but not with probe 849 (Table  2 ). In contrast, the SLT-II-producing strains listed in Table 2 reacted with probe 849 but not with the SLT-I probes. No hybridization signals occurred with the nontoxigenic E. coli strains. The 12 isolates listed in Table 2 served as a standard set on each colony blot filter used for further screening of E. coli strains. After the initial testing of the probes, a variety of strains that were not of serotype 0157:H7 were screened for the presence of SLT-I and SLT-II sequences. In Table 3 , results of hybridization with the oligonucleotides are compared with the Vero cell cytotoxicity assay and ELISA techniques for SLT detection. Of 32 E. coli strains that were active on Vero cells, 27 hybridized with probe 772 and 3 hybridized with probe 849. None of the E. coli strains hybridized with both probes. Two Vero cytotoxin-producing strains belonging to serogroups 0119:H6 and 0128:H? were not identified by the use of the oligonucleotide probes. These strains were also negative in serological tests for SLT-I and SLT-II identification. When the 32 strains that produced Described by Strockbine et ai. (40) and tested by colony blot ELISA.
d Rabbit anti-SLT-It was prepared as described previously (17) (18, 40) .
b Rabbit anti-SLT-II prepared as described previously (17) and tested by dot blot ELISA.
C Positive if there were >103 CD5(Vml of culture supernatant or >103 CD50Img of cell lysate.
serotype 0157:H7 isolates that hybridized with both oligonucleotide probes, 14 reacted with anti-SLT-II and all of them hybridized with MAb 13C4. E. coli serotype 0157:H7 strains EDL931, EDL932, and EDL933 (38); strain HUS-CL40 (M. A. Karmali, Toronto); A9167-1 (2); and A9047CS1 and A8959C7 (Centers for Disease Control) are examples of dual SLT producers. A third class comprising E. coli 0157:H7 strains that were only reactive with the SLT-II probe showed considerable differences in the toxins with respect to their antigenicity and cytotoxicity to tissue cultures. Table 4 shows that the cytotoxin of only two of the four strains reacted with anti-SLT-II. Notably, the anti-SLT-II-negative strains were not cytotoxic for HeLa-S3 cells (CD50, <101/ml of culture supernatant) but were cytotoxic for Vero cells (CD50, >104/ml of culture supernatant).
Both 0157:H7 strains were associated with diarrheal disease. They were isolated from the stools of patients with nonbloody, watery diarrhea. DISCUSSION E. coli serotype 0157:H7 strains that produced cytotoxins active on HeLa and Vero cells were almost exclusively isolated from patients with hemorrhagic colitis, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome (9) . Several investigators have identified other serotypes of E. coli that produce high levels of cytotoxins for cell cultures (1, 2, 15, (19) (20) (21) 25) . In contrast to E. coli serotype 0157:H7, to date these E. coli serotypes have not been implicated in recognized outbreaks of hemorrhagic colitis or hemolytic uremic syndrome. We have recently provided epidemiological observations of a significant association of these non-0157 toxin producers with enteric disease (15) . To further support the association of these SLT producers with disease, there is a need to identify the sources and pathways of these enteric pathogens and to extend prospective case-control studies. For screening large numbers of individual strains for epidemiological surveys and for detecting small numbers of SLT-producing colonies among the physiological E. coli flora from stools of patients and healthy controls, we prepared synthetic oligonucleotides derived from the SLT-I and SLT-II genes. In this study we described the specificity of the oligonucleotides in detecting SLT-I and SLT-II sequences and compared the data from colony hybridization tests with those from cytotoxicity tests and serological assays. The usefulness of the probes was proved because (i) they displayed exquisite specificity; i.e., they did not hybridize to DNA sequences of 416 nontoxigenic strains; (ii) they detected 50 of 52 potent cytotoxin producers; and (iii) they were capable of distinguishing between SLT-I and SLT-II producers.
Of 52 strains, 2 were cytotoxic to Vero cells but did not hybridize with the oligonucleotide probes or react with antibody against SLT-I and SLT-II. At present, the reasons for the discrepancies between cytotoxicity assays and DNA hybridization are uncertain. These contrasting results may have two explanations. The strains in question either produce a novel form of SLT or express a toxin related to the group of the so-called cytolethal distending toxins recently described by Johnson and Lior (13) . The appearance of Vero cells exposed to culture supernatants or sonic lysates of both strains was similar, and the morphological effects seen within 24 h resembled those of SLTs. Studies on the cell receptor and mode of action are in progress in an effort to further characterize these toxins.
Since the successful application of colony blot hybridization for detection of ETEC (26) (8) compared heat-labile enterotoxin oligonucleotide probes with cloned enterotoxin probes and biological assays and found significantly more heat-labile enterotoxin infections with the cloned probes than with the heat-labile enterotoxin oligonucleotide probes, whereas the sensitivity between the heat-stable enterotoxin oligonucleotide probe and the cloned probe was not significant when compared with the sensitivity of the suckling mouse model (7, 8) .
Discrepancies between oligonucleotide probes and polynucleotide probes can be caused when the target DNA contains sequences that are not homologous with the sequence chosen for the oligonucleotide. If short oligonucleotides are used, the sensitivity may be affected by minor nucleotide differences in the target sequence. For the oligonucleotide probes prepared to detect slt-I sequences, we therefore investigated whether the length of the probes influenced the specificity in hybridization assays. The findings presented here with strains with defined phenotypic SLT In contrast to SLT-I, there is evidence that E. coli SLT-II is not a homogeneous toxin (35, 42) . On a molecular basis, at present, only a toxin termed SLT-IIv expressed by E. coli strains from porcine origin has been sequenced (42) . This toxin associated with edema disease in pigs is neutralized by antibody to SLT-II and hybridizes with polynucleotide DNA probes derived from the SLT-II gene of E. /oli serotype 0157:H7 strain 933 (28) . Oligonucleotide probe 849 derived from the slt-lIA gene of E. coli serotype 0157:H7 strain 933 shared 95% sequence homology with the s/t-Ih sequence published for E. coli serotype 0139 strain S1191 (42) . The oligonucleotide probe 849 hybridized with cytotoxic E. cali isolates of serotypes 0138:K81 and 0139:K82 (Table 2) . Probe 849 was successfully used to locate the genes of an SLT-II variant in E. c/oli serotype 0138: K81 strain E57 (25a) .
The data presented in Table 4 Since the genes of these toxins have not been sequenced and their mode of action has not been well characterized, we have not yet been able to define these toxins as a new category of SLTs (i.e., SLT-III). Moreover, hybridization of these strains with the oligonucleotide probe 849 suggests that DNA sequences in these strains are homologous to sequences of SLT-II. From the antigenic differences and the different spectrum of cell lines susceptible to the toxic effects, we expect nucleotide differences in other regions of the toxin genes.
Although there is no conclusive evidence that SLTs are the major virulence factors of enterohemorrhagic E. (oli, at present the SLTs are the major important marker for identification of these pathogens. Therefore, the colony hybridization test with oligonucleotides derived from the toxin genes are an alternative approach to immunological assays for SLT detection and can serve as a useful tool in defining the epidemiology of infections by this new group of enteric pathogens.
